Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?

Saved in:
Bibliographic Details
Title: Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?
Authors: Portacci A; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: a.portacci01@gmail.com., Amendolara M; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: monica.amendolara91@gmail.com., Quaranta VN; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: vitalianonicola.40@gmail.com., Iorillo I; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: iorillo.ilaria@gmail.com., Buonamico E; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: enricobuonamico@gmail.com., Diaferia F; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: fabrizio.diaferia@gmail.com., Quaranta S; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: sara.quaranta.02@gmail.com., Locorotondo C; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: cr.locorotondo@gmail.com., Schirinzi A; Institute of Clinical Pathology, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: annalisa.schirinzi@policlinico.ba.it., Boniello E; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: esterboniello@hotmail.com., Dragonieri S; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: silvano.dragonieri@uniba.it., Carpagnano GE; Institute of Respiratory Disease, Department of Translational Biomedicine and Neuroscience, University of Medicine 'Aldo Moro', Bari, Italy. Electronic address: elisiana.carpagnano@uniba.it.
Source: Respiratory medicine [Respir Med] 2024 May; Vol. 226, pp. 107628. Date of Electronic Publication: 2024 Apr 12.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3064
DOI:10.1016/j.rmed.2024.107628